Charles D Adams
Examiner (ID: 9396, Phone: (571)272-3938 , Office: P/2164 )
Most Active Art Unit | 2152 |
Art Unit(s) | 2164, 2152 |
Total Applications | 483 |
Issued Applications | 170 |
Pending Applications | 61 |
Abandoned Applications | 252 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18620333
[patent_doc_number] => 11753360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Circular economy methods of preparing unsaturated compounds
[patent_app_type] => utility
[patent_app_number] => 16/556963
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4278
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556963 | Circular economy methods of preparing unsaturated compounds | Aug 29, 2019 | Issued |
Array
(
[id] => 15454257
[patent_doc_number] => 20200039953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/547909
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547909 | Benzimidazole derivatives as bromodomain inhibitors | Aug 21, 2019 | Issued |
Array
(
[id] => 15553269
[patent_doc_number] => 20200061046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION
[patent_app_type] => utility
[patent_app_number] => 16/547164
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547164 | Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection | Aug 20, 2019 | Issued |
Array
(
[id] => 16977575
[patent_doc_number] => 20210221812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => MATRINE a-KETOAMINE COMPOUNDS, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/267961
[patent_app_country] => US
[patent_app_date] => 2019-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267961 | MATRINE a-KETOAMINE COMPOUNDS, PREPARATION METHOD THEREFOR AND USE THEREOF | Aug 13, 2019 | Pending |
Array
(
[id] => 15254099
[patent_doc_number] => 20190375783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) REGIMEN
[patent_app_type] => utility
[patent_app_number] => 16/538165
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538165 | SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) REGIMEN | Aug 11, 2019 | Abandoned |
Array
(
[id] => 17170289
[patent_doc_number] => 20210323959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHODS FOR PURIFYING ISAVUCONAZONIUM SULFATE
[patent_app_type] => utility
[patent_app_number] => 17/260682
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260682 | METHODS FOR PURIFYING ISAVUCONAZONIUM SULFATE | Jul 28, 2019 | Pending |
Array
(
[id] => 16905221
[patent_doc_number] => 20210184137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/263135
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263135 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | Jul 22, 2019 | Pending |
Array
(
[id] => 17082011
[patent_doc_number] => 20210277017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition
[patent_app_type] => utility
[patent_app_number] => 17/261267
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261267 | Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition | Jul 17, 2019 | Pending |
Array
(
[id] => 15527143
[patent_doc_number] => 20200055877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => BETA-LACTAMASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/514904
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514904 | Beta-lactamase inhibitors | Jul 16, 2019 | Issued |
Array
(
[id] => 18716403
[patent_doc_number] => 11793724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Gelatin supply device for softgel encapsulation machine
[patent_app_type] => utility
[patent_app_number] => 16/508808
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 5757
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16508808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/508808 | Gelatin supply device for softgel encapsulation machine | Jul 10, 2019 | Issued |
Array
(
[id] => 15038451
[patent_doc_number] => 20190330230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => THIENOPYRIMIDINONE DERIVATIVE AND APPLICATION THEREOF IN PREPARING ANTICANCER DRUG
[patent_app_type] => utility
[patent_app_number] => 16/503656
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16503656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/503656 | Thienopyrimidinone derivative and application thereof in preparing anticancer drug | Jul 4, 2019 | Issued |
Array
(
[id] => 15435301
[patent_doc_number] => 20200031834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => THERAPEUTIC HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/502721
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502721 | Therapeutic heterocyclic compounds | Jul 2, 2019 | Issued |
Array
(
[id] => 17769329
[patent_doc_number] => 11401254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Substituted thiophenecarboxamides and analogues as antibacterials agents
[patent_app_type] => utility
[patent_app_number] => 17/256942
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27581
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256942 | Substituted thiophenecarboxamides and analogues as antibacterials agents | Jul 2, 2019 | Issued |
Array
(
[id] => 17067229
[patent_doc_number] => 20210269444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester
[patent_app_type] => utility
[patent_app_number] => 17/258257
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258257
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258257 | Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester | Jul 1, 2019 | Pending |
Array
(
[id] => 17082000
[patent_doc_number] => 20210277006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CRYSTALLINE SALTS OF 5-METHYL-(6S)-TETRAHYDROFOLIC ACID AND AMINO ETHYL ESTERS
[patent_app_type] => utility
[patent_app_number] => 17/258040
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258040 | CRYSTALLINE SALTS OF 5-METHYL-(6S)-TETRAHYDROFOLIC ACID AND AMINO ETHYL ESTERS | Jul 1, 2019 | Pending |
Array
(
[id] => 15267241
[patent_doc_number] => 20190382354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PHENYL AND PYRIDINYL SUBSTITUTED IMIDAZOLES AS MODULATORS OF RORyT
[patent_app_type] => utility
[patent_app_number] => 16/442864
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16442864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/442864 | Phenyl and pyridinyl substituted imidazoles as modulators of RORgT | Jun 16, 2019 | Issued |
Array
(
[id] => 14896805
[patent_doc_number] => 20190292168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => NOVEL SMALL MOLECULE BRD4 MODULATORS FOR HIV EPIGENETIC REGULATION
[patent_app_type] => utility
[patent_app_number] => 16/441748
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/441748 | Small molecule BRD4 modulators for HIV epigenetic regulation | Jun 13, 2019 | Issued |
Array
(
[id] => 17314368
[patent_doc_number] => 20210403416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Novel Modified Tetracyclines for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes
[patent_app_type] => utility
[patent_app_number] => 17/251469
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251469 | Novel Modified Tetracyclines for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes | Jun 12, 2019 | Pending |
Array
(
[id] => 16985439
[patent_doc_number] => 11072595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Benzothiophene-based selective estrogen receptor downregulator compounds
[patent_app_type] => utility
[patent_app_number] => 16/424240
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 31668
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424240 | Benzothiophene-based selective estrogen receptor downregulator compounds | May 27, 2019 | Issued |
Array
(
[id] => 16948051
[patent_doc_number] => 20210206742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PROCESS FOR THE PREPARATION OF APALUTAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/059551
[patent_app_country] => US
[patent_app_date] => 2019-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059551 | Process for the preparation of apalutamide | May 26, 2019 | Issued |